Key result
Prenatal administration of indomethacin for polyhydramnios restored amniotic fluid volume but caused constriction of the fetal ductus arteriosus and right heart failure.
Case Report (n=1)
Prenatal indomethacin for polyhydramnios can cause fetal ductus arteriosus constriction and right heart failure, necessitating close fetal echocardiographic monitoring.
Answers are grounded in this paper and cite their sources.
Requires fetal ductal monitoring with indomethacin for polyhydramnios; leaves open incidence and reversibility in larger cohorts.
Prenatal administration of indomethacin for the treatment of polyhydramnios at 27 weeks' gestation resulted in the rapid restoration of normal amniotic fluid volume. However, after 16 days therapy, fetal echocardiography revealed constriction of the fetal ductus arteriosus which did not reverse during the 17 days after the therapy was discontinued. The constriction resulted in right heart failure but no long-term effects on the infant after birth. Indomethacin is a powerful treatment for polyhydramnios but its use requires close monitoring of the fetal heart.
No takes yet. Share an insight, caveat, or question.
MBBS et al. (2008) conducted a case report in Polyhydramnios (n=1). Indomethacin was evaluated on Constriction of the fetal ductus arteriosus and restoration of amniotic fluid volume. Prenatal administration of indomethacin for polyhydramnios restored amniotic fluid volume but caused constriction of the fetal ductus arteriosus and right heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: